Aculys Pharma, Inc. is a Japanese clinical-stage biopharmaceutical company focused on neurological and psychiatric diseases where there is high unmet medical need. The company works to eliminate Japan's drug lag and drug loss by bringing innovative medicines already approved in Western markets to Japanese patients as early as possible. - View it on GitHub